ESR1 and breast carcinoma: Estrogen receptor-alpha (ERα) is critical for mammary gland development and plays a key role in tumor progression and in determining whether a patient is eligible for endocrine therapy; 75% of diagnosed breast cancers are ERα-positive [4,5].